title: Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells.
abstract: Wnt/β-catenin signaling plays a pivotal role in regulating cell growth and differentiation by activation of the β-catenin/T-cell factor (TCF) complex and subsequent regulation of a set of target genes that have one or more TCF-binding elements (TBEs). Hyperactivation of this pathway has been implicated in numerous malignancies including human neuroendocrine tumors (NETs). Neurotensin (NT), an intestinal hormone, induces proliferation of several gastrointestinal (GI) cancers including cancers of the pancreas and colon. Here, we analyzed the human NT promoter in silico and found at least four consensus TBEs within the proximal promoter region. Using a combination of ChIP and luciferase reporter assays, we identified one TBE (located ∼900 bp proximal from the transcription start site) that was immunoprecipitated efficiently by TCF4-targeting antibody; mutation of this site attenuated the responsiveness to β-catenin. We also confirmed that the promoter activity and the mRNA and protein expression levels of NT were increased by various Wnt pathway activators and decreased by Wnt inhibitors in NET cell lines BON and QGP-1, which express and secrete NT. Similarly, the intracellular content and secretion of NT were induced by Wnt3a in these cells. Finally, inhibition of NT signaling suppressed cell proliferation and anchorage-independent growth and decreased expression levels of growth-related proteins in NET cells. Our results indicate that NT is a direct target of the Wnt/β-catenin pathway and may be a mediator for NET cell growth.
authors.affiliation: Markey Cancer Center, University of Kentucky, Lexington, KY.
authors.forename: Ji Tae
authors.initials: JT
authors.lastname: Kim
authors.forename: Chunming
authors.initials: C
authors.lastname: Liu
authors.forename: Yekaterina Y
authors.initials: YY
authors.lastname: Zaytseva
authors.forename: Heidi L
authors.initials: HL
authors.lastname: Weiss
authors.forename: Courtney M
authors.initials: CM
authors.lastname: Townsend
authors.forename: B Mark
authors.initials: BM
authors.lastname: Evers
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018358:Neuroendocrine Tumors / Q000473:pathology*; D009496:Neurotensin / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D011401:Promoter Regions, Genetic; D018028:Receptors, Neurotensin / Q000502:physiology; D060449:Wnt Signaling Pathway / Q000502:physiology*; D051176:beta Catenin / Q000502:physiology*
chemical_list: C495270:CTNNB1 protein, human; D018028:Receptors, Neurotensin; D051176:beta Catenin; C114036:neurotensin type 1 receptor; D009496:Neurotensin
keywords: Wnt/β-catenin pathway; neuroendocrine tumor cells; neurotensin; target gene
references.citation: J Clin Invest. 2000 Aug;106(4):533-9
references.pmid: 10953028
references.citation: Mol Endocrinol. 2012 Aug;26(8):1380-93
references.pmid: 22700584
references.citation: Dev Cell. 2009 Jul;17(1):9-26
references.pmid: 19619488
references.citation: Peptides. 2006 Oct;27(10):2424-33
references.pmid: 16904238
references.citation: Cleve Clin J Med. 2008 Dec;75(12):849-55
references.pmid: 19088003
references.citation: Science. 1997 Mar 21;275(5307):1787-90
references.pmid: 9065402
references.citation: Epigenetics. 2009 Jul 1;4(5):307-312
references.pmid: 28001119
references.citation: Nat Rev Cancer. 2008 May;8(5):387-98
references.pmid: 18432252
references.citation: Biochim Biophys Acta. 2013 Mar;1833(3):573-82
references.pmid: 23220008
references.citation: J Clin Invest. 1995 Jun;95(6):2822-30
references.pmid: 7769122
references.citation: Nature. 1996 Aug 15;382(6592):638-42
references.pmid: 8757136
references.citation: Am J Physiol. 1998 Mar;274(3):G535-43
references.pmid: 9530155
references.citation: Carcinogenesis. 2006 Apr;27(4):708-16
references.pmid: 16299383
references.citation: Regul Pept. 2011 Oct 10;170(1-3):7-17
references.pmid: 21549161
references.citation: Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):5954-63
references.pmid: 21393571
references.citation: Cell. 2002 Oct 18;111(2):251-63
references.pmid: 12408869
references.citation: Gastroenterology. 1991 Aug;101(2):303-11
references.pmid: 1712329
references.citation: Cell. 2002 Oct 18;111(2):241-50
references.pmid: 12408868
references.citation: Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65-9
references.pmid: 8380498
references.citation: Cancer Res. 2001 Aug 15;61(16):6050-4
references.pmid: 11507052
references.citation: Am J Physiol Cell Physiol. 2011 Jul;301(1):C213-26
references.pmid: 21508335
references.citation: Front Endocrinol (Lausanne). 2013 Jan 17;3:184
references.pmid: 23335914
references.citation: Cell. 1997 Mar 21;88(6):789-99
references.pmid: 9118222
references.citation: Adv Surg. 2011;45:285-300
references.pmid: 21954695
references.citation: Carcinogenesis. 2013 May;34(5):953-61
references.pmid: 23354304